Macrovascular Disease in Type 2 Diabetes
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The patient who is Voluntary to participate in this study, and sign the informed consent; (2) Aged 18 to 70 years; (3) In accordance with the diagnostic criteria of type 2 diabetes mellitus and meet the diagnostic criteria of TCM syndrome of deficiency, phlegm,or stasis; (4) Type 2 diabetic patients of glycosylated hemoglobin is less than 7%.
Exclusion criteria
Exclusion criteria: (1) With a serious heart, brain, liver, kidney, blood hematopoietic system of primary diseases and psychosis patients; (2) Acute diabetes complications, including diabetic ketoacidosis, diabetes, high permeability of ketosis coma, hypoglycemia coma or severe unconsciousness hypoglycemia, etc; (3) Pregnant or lactating women; (4) suffering from severe infections within 1 month; (5) People who are using insulin, aspirin(>300mg/d), PPAR-alpha ligands, PPAR-gama ligands; (6) Allergies or allergic reactions to drugs used in this study; (7) People who are uncooperative during the start-up stage; (8) people who have drug or other substance abuse or alcoholics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CRP;TNF-a;FIB;Carotid atherosclerotic plaque;AGEs;Oxidative Stress Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Glucose;HbA1c;Blood Lipid;Hemorheology;Coagulation function; | — |
Countries
China
Contacts
Chengdu University of Traditional Chiese Medicine